Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

347891

registered interest
date	02/06/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Mental Illness: Children and Young People
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government what steps they are taking to address the reported rise in the number of children suffering from mental health issues.
tabling member printed	Lord Taylor of Warwick
uin	HL177
answer	answer is ministerial correction date of answer 15/06/2015 answer text <p>This Government is committed to improving children and young people’s mental health and wellbeing.</p><p>The Department is working with NHS England and other partners to consider how best to drive forward transformation in children and young people’s mental health and wellbeing. The Children and Young People's Improving Access to Psychological Therapies (CYP IAPT) programme is already being expanded to cover additional areas of clinical practice, so that by 2018 children and young people across all of England will have access to evidence based psychotherapies. The Department is also commissioning a new national survey on the prevalence of mental health problems in children and young people, the first since 2004.</p><p> </p> answering member printed Lord Prior of Brampton question first answered 15/06/2015 11:34:24 answering member 127 label Biography information for Lord Prior of Brampton
tabling member	1796 label Biography information for Lord Taylor of Warwick

347892

registered interest
date	02/06/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Maternity Services
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government what steps they are taking to improve access to healthcare for all mothers, regardless of their wealth or immigration status.
tabling member printed	Lord Taylor of Warwick
uin	HL178
answer	answer is ministerial correction date of answer 15/06/2015 answer text <p>All women regardless of their wealth or immigration status are encouraged to contact their maternity services as soon as they know they are pregnant for a full assessment of their health, risk factors and choices so that a personalised plan of care can be prepared. The latest data shows that over 96% of pregnant women in England received their full health and risk assessment before 12 weeks and 6 days between April and June 2014. Early access to maternity services helps tackle the negative impact of health inequalities from the start of life and supports good health and well-being in mother and baby.</p><p> </p><p>Women with complex social factors do not always access maternity services early, or attend regularly for antenatal care and poorer outcomes are consequently reported for mother and baby. Maternity services need to be proactive in engaging all women. To support National Health Service maternity services engagement with pregnant women with complex social factors, the National Institute for Health and Care Excellence has published clinical guidelines on pregnancy and complex social factors, which describes how access to care can be improved and contact with antenatal care maintained.</p><p> </p><p>Maternity services feature prominently in the key objectives set out in the Mandate between the Government and NHS England. All women, regardless of their wealth or immigration status, should have a named midwife responsible for ensuring she receives personalised care throughout pregnancy, childbirth and during the postnatal period. To help reduce unwarranted variation in service delivery and encourage innovation, NHS England has established Maternity and Children Strategic Clinical Networks.<strong> </strong></p><p> </p><p>Entitlement to free NHS hospital treatment in England is based on being ‘ordinarily resident’ in the United Kingdom. Except in rare circumstances, nationals of countries outside the European Economic Area must also have ‘indefinite leave to remain’ in the UK in order to be ordinarily resident here. Anyone not ordinarily resident here is subject to the NHS (Charges to Overseas Visitors) Regulations 2015, and will be charged for any treatment they receive unless an exemption from charge category applies.</p><p> </p><p>Chargeable treatment which is considered by clinicians to be immediately necessary, must never be withheld from an overseas visitor. Guidance to NHS trusts makes clear that all maternity services – including routine ante-natal treatment - should be regarded as immediately necessary. This means that no woman will be denied maternity services, even if she cannot pay in advance, although she will still be charged for treatment and expected to pay later.</p><p> </p> answering member printed Lord Prior of Brampton question first answered 15/06/2015 11:33:23 answering member 127 label Biography information for Lord Prior of Brampton
tabling member	1796 label Biography information for Lord Taylor of Warwick

347896

registered interest
date	02/06/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	IVF
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government what discussions they have had with other governments regarding the decision of the United Kingdom to permit germline modifications for the purposes of preventing the transmission of mitochondrial disease; and what, if any, concerns were raised during those discussions.
tabling member printed	Lord Alton of Liverpool
uin	HL182
answer	answer is ministerial correction date of answer 16/06/2015 answer text <p>The Government has had no discussions with other international governments about Parliament’s decision to pass the Human Fertilisation and Embryology (Mitochondrial Donation) Regulations 2015. Although a matter reserved to the Westminster Parliament, the Government has kept the Devolved Administrations informed about the development of these regulations. Information is not routinely collected by the Department about other countries’ approaches to addressing mitochondrial disease.</p><p> </p><p> </p><p> </p><p>The Government has made no formal assessment of the statement by Mr John Holdren, Director of the White House Office of Science and Technology Policy, however we understand that his comments were not in relation to mitochondrial donation.</p><p> </p> answering member printed Lord Prior of Brampton question first answered 16/06/2015 14:12:57 answering member 127 label Biography information for Lord Prior of Brampton
tabling member	738 label Biography information for Lord Alton of Liverpool

347897

registered interest
date	02/06/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	IVF
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government whether they collect information on whether other countries permit germline modification for the purposes of preventing the transmission of mitochondrial disease.
tabling member printed	Lord Alton of Liverpool
uin	HL183
answer	answer is ministerial correction date of answer 16/06/2015 answer text <p>The Government has had no discussions with other international governments about Parliament’s decision to pass the Human Fertilisation and Embryology (Mitochondrial Donation) Regulations 2015. Although a matter reserved to the Westminster Parliament, the Government has kept the Devolved Administrations informed about the development of these regulations. Information is not routinely collected by the Department about other countries’ approaches to addressing mitochondrial disease.</p><p> </p><p> </p><p> </p><p>The Government has made no formal assessment of the statement by Mr John Holdren, Director of the White House Office of Science and Technology Policy, however we understand that his comments were not in relation to mitochondrial donation.</p><p> </p> answering member printed Lord Prior of Brampton grouped question UIN HL184 question first answered 16/06/2015 14:14:11 answering member 127 label Biography information for Lord Prior of Brampton
tabling member	738 label Biography information for Lord Alton of Liverpool

347898

registered interest
date	02/06/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	IVF
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government what assessment they have made of the statement of the government of the United States on 26 May that "altering the human germline for clinical purposes is a line that should not be crossed at this time"; and the statement by the Director of the White House Office of Science and Technology Policy that "the full implications of such a step could not be known until a number of generations had inherited the genetic changes made – and choices made in one country could affect all of us".
tabling member printed	Lord Alton of Liverpool
uin	HL184
answer	answer is ministerial correction date of answer 16/06/2015 answer text <p>The Government has had no discussions with other international governments about Parliament’s decision to pass the Human Fertilisation and Embryology (Mitochondrial Donation) Regulations 2015. Although a matter reserved to the Westminster Parliament, the Government has kept the Devolved Administrations informed about the development of these regulations. Information is not routinely collected by the Department about other countries’ approaches to addressing mitochondrial disease.</p><p> </p><p> </p><p> </p><p>The Government has made no formal assessment of the statement by Mr John Holdren, Director of the White House Office of Science and Technology Policy, however we understand that his comments were not in relation to mitochondrial donation.</p><p> </p> answering member printed Lord Prior of Brampton grouped question UIN HL183 question first answered 16/06/2015 14:14:11 answering member 127 label Biography information for Lord Prior of Brampton
tabling member	738 label Biography information for Lord Alton of Liverpool

347900

registered interest
date	02/06/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Health Services: Staffordshire
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government, in the light of the Staffordshire Distressed Health Economy report by KPMG, what is their assessment of the ability of the Clinical Commissioning Groups to manage the risks posed by outsourcing to the cancer and end-of-life programme in Staffordshire for a 10-year period.
tabling member printed	Lord Hunt of Kings Heath
uin	HL186
answer	answer is ministerial correction date of answer 09/06/2015 answer text <p>NHS England advises that the Transforming Cancer and End of Life Programme in Staffordshire is a partnership between four clinical commissioning groups (CCGs), two local authorities, NHS England and Macmillan Cancer Support. Resources and expertise have been provided over and above current CCG resource by Macmillan Cancer Support to mitigate any risks to delivery from capacity and capability gaps.</p><p> </p><p> </p><p> </p><p>Staffordshire CCGs did not stipulate that private sector providers should be part of the successful consortium.</p><p> </p> answering member printed Lord Prior of Brampton grouped question UIN HL187 question first answered 09/06/2015 13:32:12 answering member 127 label Biography information for Lord Prior of Brampton
tabling member	2024 label Biography information for Lord Hunt of Kings Heath

347901

registered interest
date	02/06/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Health Services: Staffordshire
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government whether the Staffordshire Clinical Commissioning Groups stipulated that private-sector providers should be part of the successful consortium in order to manage the risk posed by outsourcing to the cancer and end-of-life programme in Staffordshire for a 10-year period; and if so, why.
tabling member printed	Lord Hunt of Kings Heath
uin	HL187
answer	answer is ministerial correction date of answer 09/06/2015 answer text <p>NHS England advises that the Transforming Cancer and End of Life Programme in Staffordshire is a partnership between four clinical commissioning groups (CCGs), two local authorities, NHS England and Macmillan Cancer Support. Resources and expertise have been provided over and above current CCG resource by Macmillan Cancer Support to mitigate any risks to delivery from capacity and capability gaps.</p><p> </p><p> </p><p> </p><p>Staffordshire CCGs did not stipulate that private sector providers should be part of the successful consortium.</p><p> </p> answering member printed Lord Prior of Brampton grouped question UIN HL186 question first answered 09/06/2015 13:32:12 answering member 127 label Biography information for Lord Prior of Brampton
tabling member	2024 label Biography information for Lord Hunt of Kings Heath

347902

registered interest
date	02/06/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Nottingham University Hospitals NHS Trust: Dermatology
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government what is their assessment of the independent investigation into the loss of dermatology specialist services at the Nottingham University Hospitals NHS Trust.
tabling member printed	Lord Hunt of Kings Heath
uin	HL188
answer	answer is ministerial correction date of answer 09/06/2015 answer text <p>The independent service review of dermatology services in Nottingham was initiated by Rushcliffe Clinical Commissioning Group (CCG), as the co-ordinating commissioner for Circle Nottingham services on behalf of the four Nottinghamshire CCGs.</p><p> </p><p> </p><p> </p><p>The review reported on 4 June 2015, finding that no one person or organisation is to blame for the current problems faced by dermatology services in Nottingham. The review panel made recommendations for joint action by Rushcliffe CCG, Circle and Nottingham University Hospital NHS Trust to address the immediate local situation. It also made a national recommendation for consideration by Health Education England.</p><p> </p> answering member printed Lord Prior of Brampton grouped question UIN HL189 question first answered 09/06/2015 13:33:00 answering member 127 label Biography information for Lord Prior of Brampton
tabling member	2024 label Biography information for Lord Hunt of Kings Heath

347903

registered interest
date	02/06/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Nottingham University Hospitals NHS Trust: Dermatology
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government what steps they are taking to hold Rushcliffe Clinical Commissioning Group to account for the failures in the commissioning of dermatology specialist services at the Nottingham University Hospital NHS Trust, described in a report of the independent investigation as an "unmitigated disaster".
tabling member printed	Lord Hunt of Kings Heath
uin	HL189
answer	answer is ministerial correction date of answer 09/06/2015 answer text <p>The independent service review of dermatology services in Nottingham was initiated by Rushcliffe Clinical Commissioning Group (CCG), as the co-ordinating commissioner for Circle Nottingham services on behalf of the four Nottinghamshire CCGs.</p><p> </p><p> </p><p> </p><p>The review reported on 4 June 2015, finding that no one person or organisation is to blame for the current problems faced by dermatology services in Nottingham. The review panel made recommendations for joint action by Rushcliffe CCG, Circle and Nottingham University Hospital NHS Trust to address the immediate local situation. It also made a national recommendation for consideration by Health Education England.</p><p> </p> answering member printed Lord Prior of Brampton grouped question UIN HL188 question first answered 09/06/2015 13:33:01 answering member 127 label Biography information for Lord Prior of Brampton
tabling member	2024 label Biography information for Lord Hunt of Kings Heath

347904

registered interest
date	02/06/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Dermatology: Nottingham
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government what assessment they have made of whether all locums employed by CircleNottingham are qualified to be included on the General Medical Council specialist register for dermatology specialist services.
tabling member printed	Lord Hunt of Kings Heath
uin	HL190
answer	answer is ministerial correction date of answer 15/06/2015 answer text <p>No assessment has been made by the Department of whether all locums employed by Circle Nottingham, an independent organisation, are qualified to be included on the General Medical Council specialist register for dermatology specialist services.</p><p>Circle Health Limited is an independent organisation. It is for the employer, not the Department, to ensure its employees are appropriately skilled, trained, qualified and professionally registered for the roles they are fulfilling.</p><p> </p> answering member printed Lord Prior of Brampton question first answered 15/06/2015 11:35:28 answering member 127 label Biography information for Lord Prior of Brampton
tabling member	2024 label Biography information for Lord Hunt of Kings Heath